TMC Life Sciences Bhd operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares TMC Life Sciences Bhd with three other
health care providers in Asia:
Oue Lippo Healthcare Ltd
sales of 43.57 million Singapore Dollars [US$33.16 million]
Nawaloka Hospitals PLC
of Sri Lanka
(6.30 billion Sri Lanka Rupees [US$40.51 million]
Ceylon Hospitals PLC
based in Sri Lanka
(5.29 billion Sri Lanka Rupees [US$34.01 million]
TMC Life Sciences Bhd reported sales of 151.71 million Malaysian Ringgits (US$38.73 million)
August of 2017.
increase of 17.4%
versus 2016, when the company's sales were 129.21 million Malaysian Ringgits.
Sales at TMC Life Sciences Bhd have increased during each of the previous five years
(and since 2012, sales have increased a total of 145%).